醫師學術論文
Paper林有騫 You-Cian Lin 心臟血管外科主任
林有騫(林暉翰)醫師擅長於各式心臟手術主動脈剝離混成式手術、不跳停冠狀動脈全動脈繞道手術、心臟瓣膜修補及置換手術、心律不整燒灼術。
除此之外林醫師亦是血管外科專家,包括
1.心臟:微創及達文西開心手術、不跳停冠狀動脈全動脈繞道手術、瓣膜修補手術、心律不整手術
2.主動脈支架:主動脈剝微創支架手術、主動脈剝離混成式手術、胸腹主動脈瘤微創支架手術
3.心臟移植及心臟輔助器裝手術
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 林有騫(Lin, You-Cian)、(Wei-Chun Wang)、(Hsiang-Lin Lee,)、(Jaw-Ji Tsai)、(Shao-Hsuan Kao)*,House dust mite allergen Der f 2 drives IL-6 and GM–CSF expression in airway epithelial cells via p38 MAPK/NF-κB signaling,JOURNAL OF ASTHMA,2024 May,62(2024): | 2024 . 05 |
2 | 施宏謀(Hong-Mo Shih)、林韋均(Wei-Jun Lin)、林有騫(Lin, You-Cian)、張詩聖(Shih-Sheng Chang)、張坤正(Kuan-Cheng Chang)、余紹華(Shao-Hua Yu)*,Extracorporeal cardiopulmonary resuscitation for patients with refractory out-of-hospital cardiac arrest: a propensity score matching, observational study.,Scientific Reports,2024 Apr,14(1):9912 | 2024 . 04 |
3 | 林有騫(Lin, You-Cian)、(Jeen-Chen Chen)、(Jiunn-Min Lin)、許智翔(Chih-Hsiang Hsu)、吳青(Ching-Feng Wu)、(Shao-Hsuan Kao)*,Differential serum proteomic signatures between acute aortic dissection and acute myocardial infarction,Biomedicines,2023 Jan,(): | 2023 . 01 |
4 | 何璟霖(Ching-Lin, Ho)、林俊閔(Jiunn-Miin Lin)、許智翔(Chih-Hsiang Hsu)、林有騫(Lin, You-Cian)*,A Comparison of the Short-Term Outcomes after Use of Aorto-Uni-Iliac Versus Bifurcated Endografts for Endovascular Repair of Ruptured Abdominal Aortic Aneurysms,ANNALS OF VASCULAR SURGERY,2022 Sep,(): | 2022 . 09 |
5 | (Yung-Kuan Chan)*、林有騫(Lin, You-Cian)、(Wei-Jyun Wang)、(Wan-Ting Hu)、(Chuen-Horng Lin)*、(Shyr-Shen Yu),Identifying the occlusion of left subclavian artery with stent based on chest MRI images,MULTIMEDIA TOOLS AND APPLICATIONS,2022 Sep,(): | 2022 . 09 |
6 | 何璟霖(Ching-Lin, Ho)、(Teressa Reanne Ju)、(Chi Chan Lee)、(Hsin-Ti Lin)、(Alexander-Lee Wang)、(Robert Jeenchen Chen)、林有騫(Lin, You-Cian)*,The Early Dynamic Change in Cardiac Enzymes and Renal Function Is Associated with Mortality in Patients with Fulminant Myocarditis on Extracorporeal Membrane Oxygenation: Analysis of a Single Center’s Experience,Healthcare,2022 Jun,10():1063 | 2022 . 06 |
7 | (Jhen-Yu Huang)、林有騫(Lin, You-Cian)、(Han-Min Chen)、(Jiun-Tsai Lin)、(Shao-Hsuan Kao)*,Adenine Combined with Cisplatin Promotes Anticancer Activity against Hepatocellular Cancer Cells through AMPK-Mediated p53/p21 and p38 MAPK Cascades,Pharmaceuticals,2022 Jun,15():795 | 2022 . 06 |
8 | (Ching-Pei Chen)、林有騫(Lin, You-Cian)、(Yu-Hui Peng)、(Han-Min Chen)、(Jiun-Tsai Lin)、(Shao-Hsuan Kao)*,Rosmarinic Acid Attenuates the Lipopolysaccharide-Provoked Inflammatory Response of Vascular Smooth Muscle Cell via Inhibition of MAPK/NF-κB Cascade,Pharmaceuticals,2022 Mar,2022(15):437 | 2022 . 03 |
9 | (Chien-Wei Huang)、林有騫(Lin, You-Cian)、(Chia-Hung Hung)、(Han-Min Chen)、(Jiun-Tsai Lin)、(Chau-Jong Wang)、(Shao-Hsuan Kao)*,Adenine Inhibits the Invasive Potential of DLD-1 Human Colorectal Cancer Cell via the AMPK/FAK Axis,Pharmaceuticals,2021 Aug,14():860 | 2021 . 08 |
10 | 連禹軒(Yu-Hsien Lian)、陳勁辰(Robert Jeenchen Chen)*、林有騫(Lin, You-Cian),A case report of acquired methemoglobinemia rescued by veno-venous extracorporeal membrane oxygenation,MEDICINE,2021 Apr,0(): | 2021 . 04 |
11 | 林俊閔(LIN JIUNN-MIIN)、許智翔(Chih-Hsiang Hsu)、陳勁辰(Jeen-Chen Chen)、高紹軒(Shao-Hsuan Kao)、林有騫(Lin, You-Cian)*,BCL-6 promotes the methylation of miR-34a by recruiting EZH2 and upregulates CTRP9 to protect ischemic myocardial injury,BIOFACTORS,2020 Dec,(): | 2020 . 12 |
12 | 張容光(Yung Kuan Chan)、林有騫(Hui-Han Lin)*、(Keng-Chang Tu)、(Wan-Ting Hu)、(Shyr Shen Yu),Relationship Between the Sizes of Blood Vessel and Selected Stent,American Journal of Biomedical Science & Research,2020 Sep,(): | 2020 . 09 |
13 | 黃子旻(Tzu-Min Huang)、陳建勳(Jian-Xun Chen)*、林有騫(Hui-Han Lin)、方信元(Hsin-Yuan Fang),【EDITORIAL MATERIAL】Chest echo as a tool for finding penetrating atherosclerotic ulcers with aortic intramural hematoma in progress,EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY,2020 Jun,(): | 2020 . 06 |
14 | 翁啟峰(Chia-Fong Weng)、吳青(Ching-Feng Wu)、高紹軒、陳勁辰(CHEN CHEN-JEEN)、林暉翰(Hui-Han Lin)*,Down-Regulation of miR-34a-5p Potentiates Protective Effect of Adipose-Derived Mesenchymal Stem Cells Against Ischemic Myocardial Infarction by Stimulating the Expression of C1q/Tumor Necrosis Factor-Related Protein-9,Frontiers in Physiology,2019 Dec,10():1445 | 2019 . 12 |
15 | (Shyh-Ren Chiang)、(Chun-Shiang Lin)、林暉翰(Hui-Han Lin)、(Pei-Chen Shi)、(Shao-Hsuan Kao)*,Bergapten induces G1 arrest of non‑small cell lung cancer cells, associated with the p53‑mediated cascade,Molecular Medicine Reports,2019 Jan,(19):2401-2407 | 2019 . 01 |
16 | (Ching-pin Lin)、(Chun-Shiang Lin)、林暉翰(Hui-Han Lin)、(Kuan-Te Li)、(Shao-Hsuan Kao)*、(Shih-Ming Tsao),Bergaten induces G1 arrest and pro-aptptotic cascade in colorectal cancer cells associating with p53/p21/PTEN axis,ENVIRONMENTAL TOXICOLOGY,2018 Nov,0(0):0-0 | 2018 . 11 |
17 | 林君湘(Chun-Hsianh Lin)、林暉翰(Hui-Han Lin)、(Cheng-Yi Kuo)、高紹軒(Shao-Hsuan Kao)*,Aeroallergen Der p 2 promotes motility of human non-small cell lung cancer cells via toll-like receptor-mediated up-regulation of urokinase-type plasminogen activator and integrin/focal adhesion kinase signaling,Oncotarget,2017 Jan,8(7):11316-11328 | 2017 . 01 |
18 | 林暉翰(Hui-Han Lin)*、(Liao, Shou-Fu)、吳青峰(Ching-Feng Wu)、李秉純(Ping-Chun Li)、李明禮(Ming-Li Li),Outcome of Frozen Elephant Trunk Technique for Acute Type A Aortic Dissection: As Systematic Review and Meta-Analysis,MEDICINE,2015 Apr,94(16):694-702 | 2015 . 04 |
19 | 吳汐淇(Shih-Chi Wu)*、陳自諒(William Tzu-Liang Chen)、林暉翰(Hui-Han Lin)、傅志遠(Chih-Yuan Fu)、王毓駿(Yu-Chun Wang)、羅鴻捷(Hung-Chieh Lo)、鄭翰聰(Han-Tsung Cheng)、曾佳瑋(Chia-Wei Tzeng),Use of extracorporeal membrane oxygenation in severe traumatic lung injury with respiratory failure,AMERICAN JOURNAL OF EMERGENCY MEDICINE,2015 Feb,33(2015):258-262 | 2015 . 02 |
20 | 林暉翰(Hui-Han Lin)、李明禮(Ming-Li Li)*、李秉純(Ping-Chun Li)、賴韋良(Wei-Liang Lai),Aortic Perforation as a Complication of Percutaneous Coronary Angiography,Formosan Journal of Surgery,2011 Dec,44(6):225-227 | 2011 . 12 |
21 | 林暉翰(Hui-Han Lin)、吳汐淇(Shih-Chi Wu)、陳瑞杰(Ray-Jade Chen)、林裕強(Yu-Chiang Lin)*,Malignant extrarenal rhabdoid tumors of the omentum with hemoperitoneum: Report of a case,Formosan Journal of Surgery,2010 Jan,43(): | 2010 . 01 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | Prolong Cardiopulmonary Bypass Time and High Left Atrial Volume Index as Novel Risk Factors of Atrial Fibrillation in the Long-Term After Type A Aortic Dissection Surgery,17th APHRS Scientific Sessions,雪梨,2024.09.26~2024.09.29, | 2024 . 09 |
2 | ,中區心臟血管學術會,裕元花園酒店4樓,2024.06.22~2024.06.22,Cheating Death: A Brush with the Unknown | 2024 . 06 |
3 | ,台灣周邊血管學會 第一屆第二次會員大會暨學術研討會,台中中山醫學大學9樓誠愛樓-國際會議中心,2024.04.20~2024.04.20,pulmonary endarterectomy of CTEPH 座長 | 2024 . 04 |
4 | 套膜支架對於上臂及前臂之人工動靜脈廔管反覆狹窄病灶治療成效比較之回朔性研究,113年度外科聯合學術研討會,高雄醫學大學及附設中和紀念醫院,2024.03.16~2024.03.17, | 2024 . 03 |
5 | ,TSOC winter scientific meeting,台中金典酒店,2023.12.16~2023.12.17,2021 ACC/AHA GUIDELINE FOR CORONARY REVASCULARIZATION: DOSE IT CHANGE MY CLINICAL PRACTICE: Surgeon Perspective | 2023 . 12 |
6 | ,1st Embo Tech Forum,JR東日本大飯店2F牡丹廳,2023.12.16~2023.12.16,Taiwan experience in endoleak management | 2023 . 12 |
7 | ,2023年台灣胸腔及心臟血管外科學會心臟血管外科手術縫合研討會暨實作訓練營,台中中山醫學大學誠愛樓10樓,2023.10.28~2023.10.29,心臟血管外科手術縫合實作訓練營 | 2023 . 10 |
8 | ,第 31 屆吳火獅學術研討會,新光吳火獅紀念醫院 B1 大會議室,2023.08.27~2023.08.27,Commentator for HOW I TREAT IT: CLTI and STENT-GRAFT TREATMENT FOR CENTRAL VEIN OCCLUSIVE DISEASE- WHEN TO DO AND WHAT TO USE | 2023 . 08 |
9 | 藥物及手術治療對於心內膜炎合併多重血栓及感染,台灣內科醫學會111年會員大會暨學術演講會,台大醫院國際會議中心,2022.12.3 ~2022.12.4 , | 2022 . 12 |
10 | ,台灣胸腔及心臟血管外科年會,大台南會展中心熱蘭遮廳,2022.10.29~2022.10.29,NIRS在周邊組織灌流監測的應用-中國附醫經驗之分享 | 2022 . 10 |
11 | ,Cheng Hsin Live 2021_Taipei CHIP & Aortic Symposium,視訊,2021.12.3 ~2021.12.4 ,Endovascular repair for residual type B aortic dissection with thoraco-abdominal aneurysm: report of two cases | 2021 . 12 |
12 | ,中區心臟外科病例分享研討會,林酒店七樓上海廳,2021.11.20~2021.11.20, | 2021 . 11 |
13 | ,台灣血管外科學會第九屆第一次會員大會暨學術研討會,台北萬豪酒店5樓,2021.10.23~2021.10.24,rAAA Strategy with Endurant- CUMH Experience | 2021 . 10 |
14 | ,the Asia-Pacific Extracorporeal Life Support Organization 2021 Conference (APELSO 2021),臺大醫院國際會議中心,2021.10.29~2021.10.31,心臟血管外科手術縫合實作訓練營(主動脈及二尖瓣手術指導) | 2021 . 10 |
15 | ,主動脈專家論壇,上海視訊參與,2021.09.26~2021.09.26,rAAA strategy with Endurant | 2021 . 09 |
16 | ,Medtronic Endovascular Masters Japan Meeting 2021,視訊參與日本會議,2021.02.6 ~2021.02.7 ,“Mission” of Endurant : rAAA STRATEGY WITH ENDURANT The CMUH Experience | 2021 . 02 |
17 | ,Medtronic Base Meeting,和逸飯店(高雄中山館),2021.01.9 ~2021.01.9 ,Endoanchor for rAAA : the CMUH experience | 2021 . 01 |
18 | ,TSVS2020年會,台北萬豪酒店5樓,2020.09.5 ~2020.09.6 ,Stent graft for asymptomatic penetratic aortic ulcer? Proponent | 2020 . 09 |
19 | ,8/15-16專家共識會議,三軍總醫院會議室,2020.08.15~2020.08.16, | 2020 . 08 |
20 | ,台灣血管外科學會 第八屆第一次冬季學術研討會,彰基國際培訓中心,2020.02.15~2020.02.15,中國醫藥大學附設醫院經驗分享 | 2020 . 02 |
21 | ,AORTIC HYBRID WORKSHOP,China Medical University Hospital,2019.12.16~2019.12.17,Hybrid or TEVAR with/without Heli-Fx Endoanchor | 2019 . 12 |
22 | ,Type B & type A dissection, short-neck & endoanchor,台中市西屯區市政北二路52號,2019.08.17~2019.08.17,Zero circulatory arrest time procedure for type A aortic dissection with retrograde stenting | 2019 . 08 |
23 | The Results Of Extending Indications For TEVAR Procedures To Nearly All Acute Type B Aortic Dissection,LINC ASIA-PACIFIC 2019,香港,2019.03.12~2019.03.13, | 2019 . 03 |
24 | The rationale and resulf of TEVAR procedure for Type B intramural hematoma of aorta,LINC ASIA-PACIFIC 2019,香港,2019.03.12~2019.03.13, | 2019 . 03 |
25 | 原始論文–使用1% polidocanol 靜脈內微泡沫治療主幹型及支幹型下肢靜脈曲張中國醫藥大學附設醫院一年結果,108年度外科聯合學會演講會,三軍總醫院,2019.03.16~2019.03.17, | 2019 . 03 |
26 | Four-year Surgical Results for Traumatic Aortic Injury in China Medical University Hospital, Mid-Taiwan,LINC ASIA-PACIFIC 2019,香港,2019.03.12~2019.03.13, | 2019 . 03 |
27 | Ultrasound-guided foam sclerotherapy using 1% polidocanol endovenous microfoam experience in China Medical University Hospital,Japan Endovascular Treatment Conference 2019,TKP Garden City Shinagawa 1F Shinagawa Goos, 3-13-3 Takanawa, Minato-ku, Tokyo 108-007, Japan,2019.02.22~2019.02.24, | 2019 . 02 |
28 | Successful Rescue of Acute Visceral Ischemia after Thoracic Endovascular Aortic Repair for Chronic Type B Aortic Dissection at Proximal Descending Thoracic Aorta,Japan Endovascular Treatment Conference 2019,TKP Garden City Shinagawa 1F Shinagawa Goos, 3-13-3 Takanawa, Minato-ku, Tokyo 108-007, Japan,2019.02.22~2019.02.24, | 2019 . 02 |
29 | 4-year result of TEVAR procedure for acute type B aortic dissection in China Medical University Hospital,JET 2019, Japan Endovascular Treatment Conference 2019,TKP Garden City Shinagawa, Tokyo, Japan,2019.02.22~2019.02.24, | 2019 . 02 |
30 | A case of acute limb ischemia with cholesterol emboli after endovascular approach,Japan Endovascular Treatment Conference 2019,TKP Garden City Shinagawa 1F Shinagawa Goos, 3-13-3 Takanawa, Minato-ku, Tokyo 108-007, Japan,2019.02.22~2019.02.24, | 2019 . 02 |
31 | ,Aortic symposium,台北,2018.12.22~2018.12.22,急性A型主動脈剝離的手術-中國附醫經驗 | 2018 . 12 |
32 | ,Valiant Captivia 心胸外科专家学术沙龙,台中市西區民權路,2018.03.25~2018.03.30,CMUH Hybrid Experience Sharing | 2018 . 03 |
33 | ,心胸外科专家学术沙龙,中國醫藥大學附設醫院會議室,2017.07.23~2017.07.28,中國Candy plug經驗分享/中國Retrograde hybrid經驗分享 | 2017 . 07 |
34 | ,103年度台灣血管外科學會冬季學術研討會,光田綜合醫院第二醫療大樓八樓國際會議廳,2014.12.6 ~2014.12.7 ,live case EVAR | 2014 . 12 |
35 | Infective Endocarditis of Aortic Valve Complicated by Periannular Abscesses assessed by 4-dimentional Echocardiography,2014 海峽兩岸醫藥衛生交流協會超聲醫學專家委員會暨第六屆海峽兩岸超聲醫學高端論壇暨台灣心臟超音波學會第七屆第一次會員大會,台中榮民總醫院研究大樓,2014.05.25~2014.05.25, | 2014 . 05 |
36 | Salmonella Mycotic Aneurysm: Experience of CMUH,台灣外科醫學會九十七年度外科聯合學術演講會,高雄榮民總醫院,2008.03.29~2008.03.30, | 2008 . 03 |
專書
暫無資料研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,MOST 110-2314-B-039-013,林有騫(Lin, You-Cian)、姜秀穎(Hsiu-Yin Chiang)、郭錦輯(Kuo, Chin-Chi),科技部,利用密集之尿液監測及生物標記早期診斷體外循環術後之急性腎損傷,2021.8.1~2022.7.31 | 2021 . 08 |
2 | 個別型,DMR-111-049,高紹軒,附醫院內計畫,探討血清碳酸酐酶III作為分辨主動脈剝離與冠心病病人之生物標的潛力以及在主動脈剝離病程中可能扮演的角色,2021.8.1~2022.7.31 | 2021 . 08 |
3 | 個別型,DMR-111-050,林有騫(Lin, You-Cian)、郭正宜,附醫院內計畫,抗原嵌合接受體T細胞治療心臟纖維化之研究,2021.8.1~2022.7.31 | 2021 . 08 |
4 | 個別型,DMR-109-035,高紹軒,附醫院內計畫,主動脈剝離潛在生物標誌蛋白與臨床表徵之關聯性研究,2019.8.1~2020.7.31 | 2019 . 08 |
5 | 個別型,MOHW108-TDU-B-212-133004,林昭庚(Jaung-Geng Lin)、蔡輔仁(Fuu-Jen Tsai)、林正介(Cheng-Chieh Lin)、趙坤山(Kun-San Chao)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、張建國(Jan-Gowth Chang)、卓夙航(Suh-Hang Juo)、張恒鴻(Hen-Hong Chang)、江舟峰、藍先元(Hsien-Yuan Lane)、徐偉成(Woei-Cheang Shyu)、蘇冠賓(Kuan-Pin Su)、陳培君(PEI-CHUN CHEN)、陳怡文(Yi-Wen Chen)、蔡崇豪(Chon-Haw Tsai)、謝慶良(Ching-Liang Hsieh)、李采娟(Tsai-Chung Li)、白禮源(Li-Yuan Bai)、宋鴻樟(Fung-Chung J Sung)、周宜卿(I-Ching Chou)、葉士芃(Shih-Peng Yeh)、謝右文(Yow-Wen Hsieh)、劉崇祥(Chung-Hsiang Liu)、林嘉德(Chia-Der Lin)、洪士杰(Shih-Chieh Hung)、梁基安(Ji-An Liang)、顏宏融(Hung-Rong Yen)、孟乃欣(Nai-Hsin Meng)、黃秋錦(Chiu-Ching Huang)、王怡寬(I-Kuan Wang)、賴世偉(Lai, Shih-Wei)、張坤正(Kuan-Cheng Chang)、劉秋松(Chiu-Shong Liu)、溫啟邦(Chi-Pang Wen)、林志學(Chih-Hsueh Lin)、陳清助(Ching-Chu Chen)、高嘉鴻(Chia-Hung Kao)、蔡文正(Tsai, Wen-Chen)、余養豪、楊良友(Liang-Yo Yang)、温永銳(Yeong-Ray Wen)、楊榮林(Rong-Lin Yang)、呂明桂(Ming-Kuei Lu)、林暉翰(Hui-Han Lin)、薛榮銀、田霓(Ni Tien),衛福部,精進臨床試驗能量及國際躍升計畫,2019.1.1~2019.12.31 | 2019 . 01 |
6 | 個別型,MOHW107-TDU-B-212-123004,林昭庚(Lin, Jaung-Geng)、蔡輔仁(Tsai, Fuu-Jen)、林正介(Lin, Cheng-Chieh)、趙坤山(Chao, Kun-San)、陳明豐(Chen, Ming-Fong)、周德陽(Cho, Der-Yang)、張建國(Chang, Jan-Gowth)、卓夙航(Juo, Suh-Hang)、張恒鴻(Chang, Hen-Hong)、薛榮銀、藍先元(Lane, Hsien-Yuan)、徐偉成(Shyu, Woei-Cherng)、蘇冠賓(Su, Kuan-Pin)、陳怡文(Chen, Yi-Wen)、謝慶良(Hsieh, Ching-Liang)、蔡崇豪(Tsai, Chon-Haw)、白禮源(Bai, Li-Yuan)、李采娟(Li, Tsai-Chung)、周宜卿(Chou, I-Ching)、宋鴻樟(Sung, Fung-Chang)、謝右文(Hsieh, Yow-Wen)、葉士芃(Yeh, Su-Peng)、林嘉德(Lin, Chia-Der)、劉崇祥(Liu, Chung-Hsiang)、梁基安(Liang, Ji-An)、洪士杰(Hung, Shih-Chieh)、孟乃欣(Meng, Nai-Hsin)、顏宏融(Yen, Hung-Rong)、王怡寬(Wang, I-Kuan)、黃秋錦(Huang, Chiu-Ching)、張坤正(Chang, Kuan-Cheng)、賴世偉(Lai, Shih-Wei)、溫啟邦(Wen, Chi-Pang)、劉秋松(Liu, Chiu-Shong)、陳清助(Chen, Ching-Chu)、林志學(Lin, Chih-Hsueh)、蔡文正(Tsai, Wen-Chen)、高嘉鴻(Kao, Chia-Hung)、楊良友(Yang, Liang-Yo)、余養豪(Yu, Yang-Hao)、楊榮林(Yang, Rong-Lin)、温永銳(Wen, Yeong-Ray)、林暉翰(Hui-Han Lin)、呂明桂(Lu, Ming-Kuei)、田霓(Tien, Ni),衛福部,精進臨床試驗能量及國際躍升計畫,2018.1.1~2018.12.31 | 2018 . 01 |
7 | 臨床試驗與研究計畫,CMUH106-REC2-103,,附醫廠商計畫,大口徑心導管術後止血裝置(XProTM System)之前瞻性、單臂、多中心臨床試驗,2017.1.1~2017.12.31 | 2017 . 01 |
8 | 個別型,DMR-106-033,高紹軒,附醫院內計畫,探討單磷酸腺苷活化蛋白激酶活化劑抑制腫瘤壞死因子誘發人類心肌細胞凋亡之分子機轉,2016.8.1~2017.7.31 | 2016 . 08 |
專利技術
暫無資料獲獎事蹟
獲獎/Award (獲獎名稱,給獎單位,獲獎日期) |
日期 | |
1 | 2022第一屆跨領域全人照護及教學最佳口頭報告論文獎,第一屆跨領域全人照護及教學線上發表展暨研討會,2022.7.9 | 2022 . 07 |
2 | 2021台灣急重症醫療品質競賽-優選,急救加護醫學會與重症醫學會,2021.12.19 | 2021 . 12 |